Miguel Forte
President, ISCT, board member of ARM and CEO of Kiji Therapeutics
False
Advertisement
Now for the High-Hanging Fruit
January 22, 2019
We should be thrilled with the success of the approved CD-19 CAR-T therapies. But the field is still young, and we are only scratching the surface of what’s possible.
0 min read
The TCRs Are Coming
December 14, 2019
It’s time to fine-tune the way we target solid tumors
1 min read
Advanced Medicines: Making it to Market
August 19, 2019
We’ve learned a number of lessons when it comes to developing and manufacturing cell therapies, including the importance of keeping our eyes on the end goal of commercial manufacturing – even at the earliest stages.
1 min read
Musings from The Power List: Miguel Forte
September 8, 2026
Scientific progress alone isn't enough, says Miguel Forte, who argues that reimbursement and patient access will shape the next decade of cell and gene therapy
4 min read
Newsletters
Receive the latest pharmaceutical news, personalities, education, and career development – weekly to your inbox.
